These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12022494

  • 21. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G, Qiu W, DeLuca PP.
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [Abstract] [Full Text] [Related]

  • 22. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
    Gümüşderelioglu M, Deniz G.
    J Biomater Sci Polym Ed; 2000 Mar; 11(10):1039-50. PubMed ID: 11211156
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres.
    Perugini P, Genta I, Pavanetto F, Modena T, Maculotti K, Conti B.
    J Microencapsul; 2002 Mar; 19(5):591-602. PubMed ID: 12433302
    [Abstract] [Full Text] [Related]

  • 24. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T, Yagi A, Oda Y, Nakada Y, Goto S.
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [Abstract] [Full Text] [Related]

  • 25. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
    Sehra S, Dhake AS.
    J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195
    [Abstract] [Full Text] [Related]

  • 26. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW, Song SH, Choi YW.
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [Abstract] [Full Text] [Related]

  • 27. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.
    Malaekeh-Nikouei B, Sajadi Tabassi SA, Jaafari MR.
    Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635
    [Abstract] [Full Text] [Related]

  • 28. Submicronparticles from biodegradable polymers.
    Jobmann M, Rafler G.
    Int J Pharm; 2002 Aug 21; 242(1-2):213-7. PubMed ID: 12176249
    [Abstract] [Full Text] [Related]

  • 29. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K, Muramatsu N, Kondo T.
    J Pharm Pharmacol; 1996 Sep 21; 48(9):891-5. PubMed ID: 8910847
    [Abstract] [Full Text] [Related]

  • 30. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
    Garner J, Skidmore S, Hadar J, Park H, Park K, Qin B, Wang Y.
    J Control Release; 2022 Oct 21; 350():600-612. PubMed ID: 36057396
    [Abstract] [Full Text] [Related]

  • 31. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F, Ertl B, Wirth M, Mallinger R.
    J Microencapsul; 1999 Oct 21; 16(1):1-12. PubMed ID: 9972498
    [Abstract] [Full Text] [Related]

  • 32. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z, Weisan P, Ruhua Z, Feng Z.
    Pharmazie; 2002 Oct 21; 57(10):695-7. PubMed ID: 12426951
    [Abstract] [Full Text] [Related]

  • 33. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A, Venier-Julienne MC, Saulnier P, Varlet P, Daumas-Duport C, Devauchelle P, Benoit JP.
    J Control Release; 1999 Apr 19; 58(3):311-22. PubMed ID: 10099156
    [Abstract] [Full Text] [Related]

  • 34. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH, Jiang G, Jo YW, DeLuca PP.
    Pharm Res; 2001 Nov 19; 18(11):1600-6. PubMed ID: 11758769
    [Abstract] [Full Text] [Related]

  • 35. Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
    Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H.
    J Control Release; 2005 Aug 18; 106(1-2):172-80. PubMed ID: 15936109
    [Abstract] [Full Text] [Related]

  • 36. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE, Nam YS, Lee KH, Park TG.
    J Control Release; 1999 Feb 22; 57(3):269-80. PubMed ID: 9895414
    [Abstract] [Full Text] [Related]

  • 37. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S, Tros de Ilarduya C.
    Eur J Pharm Biopharm; 2006 Jun 22; 63(2):188-97. PubMed ID: 16697172
    [Abstract] [Full Text] [Related]

  • 38. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y.
    J Pharm Sci; 1994 May 22; 83(5):727-32. PubMed ID: 8071830
    [Abstract] [Full Text] [Related]

  • 39. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X, Bodmeier R.
    J Control Release; 2006 Jan 10; 110(2):266-272. PubMed ID: 16300851
    [Abstract] [Full Text] [Related]

  • 40. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P, Ding P, Xu H, Yuan Z, Chen D, Wei J, Chen D.
    Chem Pharm Bull (Tokyo); 2006 Jan 10; 54(1):89-93. PubMed ID: 16394556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.